comparemela.com

Latest Breaking News On - Ahmedabad based veeda clinical research - Page 1 : comparemela.com

Veeda Clinical Research: CX Partners-led consortium looks to sell majority stake, eyes $600 mn -$650 mn valuation

In December 2018, a consortium of growth-oriented private equity firms led by CX Partners acquired a significant equity ownership in Veeda.

United kingdomArjun bhartiaNatco pharmaNikhil voraPranab modyBioneeds india privateVeeda clinical researchDr mahesh bhalgat as groupIndian bankUjjivan financial servicesSyngene internationala biocon group companyJubilant groupBioneeds india private limitedAhmedabad based veeda clinical researchClinical researchAvendus capital

Ahammune Biosciences completes Ph I clinical trial of vitiligo drug

Drug candidate demonstrated as both safe and efficacious for vitiligo treatment

Ahammune biosciencesVeeda clinical researchAhmedabad based veeda clinical researchClinical trials

Ahammune Biosciences, Veeda conduct human studies for vitiligo drug

The preliminary research for AB1001 was conducted at Ahammune’s R&D laboratory based out of Pune

Parul ganjuAhammune biosciencesVeeda clinical researchAhammune biosciences veeda clinical researchAhammune biosciences privatePune based ahammune biosciencesAhmedabad based veeda clinical researchExecutive directorAhammune biosciences private limitedVeeda clinical research

Ahammune Biosciences, Veeda Clinical Research conduct human studies for vitiligo drug

The preliminary research for AB1001 was conducted at Ahammune’s R&D laboratory based out of Pune

Ahammune biosciencesAhammune biosciences veeda clinical researchVeeda clinical researchPune based ahammune biosciencesAhmedabad based veeda clinical researchVeeda clinical research

vimarsana © 2020. All Rights Reserved.